Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone

GlobalNewswire
27 April 2022
https://www.globenewswire.com/news-release/2022/04/27/2430707/0/en/Statera-Biopharma-and-Immune-Therapeutics-Inc-Announce-Strategic-Agreement-for-Rights-to-Low-Dose-Naltrexone.html

Discussing Low-Dose Naltrexone with Sajad Zalzala

Lifespan.io
20 April 2022
https://www.lifespan.io/news/discussing-low-dose-naltrexone-with-sajad-zalzala/

This drug, known for curbing addictions, has shown other benefits in some patients. Dr. Zalzala responds to questions on the use of low dose naltrexone (LDN).

Topical Steroid Withdrawal (TSW)

There is a need to raise awareness about Topical Steroid Withdrawal (TSW), a serious potential side
effect of topical steroid use. TSW is not always recognized by patients or practitioners as much is still
unknown about this consequence of using topical steroids, particularly long term.1

What are skin conditions?